Associate Professor, Department of Urology
The research projects in our laboratory are centered on the mechanisms of action of metformin, the most prescribed anti–type II diabetes medicine. We are particularly interested in its antineoplastic effects and its impact on bone metabolism in diabetes.
Using various animal and cell culture models and molecular and cellular techniques, we have revealed the role of metformin as an epigenetic regulator and metabolic rebalancer, restoring normal cellular function in cancer and diabetes.
212-992-7009
212-995-4085
345 East 24th Street, 901D
New York, NY 10010
Associate Professor, Department of Urology at NYU Grossman School of Medicine
University of Michigan, Laurie McCauley
Molecular oral microbiology. 2023 Sep 16;
BMC musculoskeletal disorders. 2023 Jan 20; 24(1):48
European spine journal. 2023 Jan; 32(1):149-166
Cell. 2022 Sep 29; 185(20):3648-3651
Cell reports. 2022 Sep 20; 40(12):111389
Journal of dental research. 2022 Jun 16; 220345221102084
Journal of clinical investigation. 2022 Apr 15; 132(8):